Piramal Pharma Revenue

In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B INR with 11.99% growth. Piramal Pharma had revenue of 27.54B in the quarter ending March 31, 2025, with 7.90% growth.

Revenue

91.51B

Revenue Growth

+11.99%

P/S Ratio

2.81

Revenue / Employee

13.62M

Employees

6,719

Market Cap

257.04B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	91.51B	9.80B	11.99%
Mar 31, 2024	81.71B	10.90B	15.39%
Mar 31, 2023	70.82B	3.47B	5.16%
Mar 31, 2022	67.34B	8.47B	14.39%
Mar 31, 2021	58.87B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	272.67B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Mankind Pharma	122.07B
Aurobindo Pharma	317.24B
Fortis Healthcare	77.83B

Revenue Rankings